These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36744687)

  • 21. Digital Therapeutics in Hearing Healthcare: Evidence-Based Review.
    Kim N; Nakamura KA
    J Audiol Otol; 2024 Jul; 28(3):159-166. PubMed ID: 38973323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Technological Solutions for Diagnosis, Management and Treatment of Alzheimer's Disease-Related Symptoms: A Structured Review of the Recent Scientific Literature.
    Cammisuli DM; Cipriani G; Castelnuovo G
    Int J Environ Res Public Health; 2022 Mar; 19(5):. PubMed ID: 35270811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design of comprehensive Alzheimer's disease centers to address unmet national needs.
    Trojanowski JQ; Arnold SE; Karlawish JH; Brunden K; Cary M; Davatzikos C; Detre J; Gaulton G; Grossman M; Hurtig H; Jedrziewski K; McCluskey L; Naylor M; Polsky D; Schellenberg GD; Siderowf A; Shaw LM; Van Deerlin V; Wang LS; Werner R; Xie SX; Lee VM
    Alzheimers Dement; 2010 Mar; 6(2):150-5. PubMed ID: 20298979
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Remote Reminiscence Using Immersive Virtual Reality May Be Efficacious for Reducing Anxiety in Patients with Mild Cognitive Impairment Even in COVID-19 Pandemic: A Case Report.
    Yahara M; Niki K; Ueno K; Okamoto M; Okuda T; Tanaka H; Naito Y; Ishii R; Ueda M; Ito T
    Biol Pharm Bull; 2021; 44(7):1019-1023. PubMed ID: 34193684
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ethics of digital therapeutics (DTx).
    Refolo P; Sacchini D; Raimondi C; Spagnolo AG
    Eur Rev Med Pharmacol Sci; 2022 Sep; 26(18):6418-6423. PubMed ID: 36196692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Five weeks of immersive reminiscence therapy improves autobiographical memory in Alzheimer's disease.
    Kirk M; Rasmussen KW; Overgaard SB; Berntsen D
    Memory; 2019 Apr; 27(4):441-454. PubMed ID: 30198380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Quest for Neurodegenerative Disease Treatment-Focusing on Alzheimer's Disease Personalised Diets.
    Palimariciuc M; Balmus IM; Gireadă B; Ciobica A; Chiriță R; Iordache AC; Apostu M; Dobrin RP
    Curr Issues Mol Biol; 2023 Feb; 45(2):1519-1535. PubMed ID: 36826043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnosis of Cognitive Impairment Compatible with Early Diagnosis of Alzheimer's Disease. A Bayesian Network Model based on the Analysis of Oral Definitions of Semantic Categories.
    Guerrero JM; Martínez-Tomás R; Rincón M; Peraita H
    Methods Inf Med; 2016; 55(1):42-9. PubMed ID: 25925692
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A succinct overview of virtual reality technology use in Alzheimer's disease.
    García-Betances RI; Arredondo Waldmeyer MT; Fico G; Cabrera-Umpiérrez MF
    Front Aging Neurosci; 2015; 7():80. PubMed ID: 26029101
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects on Adherence to a Mobile App-Based Self-management Digital Therapeutics Among Patients With Coronary Heart Disease: Pilot Randomized Controlled Trial.
    Li Y; Gong Y; Zheng B; Fan F; Yi T; Zheng Y; He P; Fang J; Jia J; Zhu Q; Jiang J; Huo Y
    JMIR Mhealth Uhealth; 2022 Feb; 10(2):e32251. PubMed ID: 34906924
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Digital therapeutics in neurology.
    Abbadessa G; Brigo F; Clerico M; De Mercanti S; Trojsi F; Tedeschi G; Bonavita S; Lavorgna L
    J Neurol; 2022 Mar; 269(3):1209-1224. PubMed ID: 34018047
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Access and reimbursement pathways for digital health solutions and
    Mantovani A; Leopaldi C; Nighswander CM; Di Bidino R
    Front Med Technol; 2023; 5():1101476. PubMed ID: 36891483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alzheimer's disease; a review of the pathophysiological basis and therapeutic interventions.
    Abeysinghe AADT; Deshapriya RDUS; Udawatte C
    Life Sci; 2020 Sep; 256():117996. PubMed ID: 32585249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Episodic memory effects of gamma frequency precuneus transcranial magnetic stimulation in Alzheimer's disease: A randomized multiple baseline study.
    Traikapi A; Kalli I; Kyriakou A; Stylianou E; Symeou RT; Kardama A; Christou YP; Phylactou P; Konstantinou N
    J Neuropsychol; 2023 Jun; 17(2):279-301. PubMed ID: 36351687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The potential of virtual reality-based training to enhance the functional autonomy of Alzheimer's disease patients in cooking activities: A single case study.
    Foloppe DA; Richard P; Yamaguchi T; Etcharry-Bouyx F; Allain P
    Neuropsychol Rehabil; 2018 Jul; 28(5):709-733. PubMed ID: 26480838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Computerised cognitive training for preventing dementia in people with mild cognitive impairment.
    Gates NJ; Vernooij RW; Di Nisio M; Karim S; March E; Martínez G; Rutjes AW
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD012279. PubMed ID: 30864747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exploring the Category and Use Cases on Digital Therapeutic Methodologies.
    An S; Ko J; Yu KS; Kwon H; Kim S; Hong J; Kong HJ
    Healthc Inform Res; 2023 Jul; 29(3):190-198. PubMed ID: 37591674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conceptualizing socially-assistive robots as a digital therapeutic tool in healthcare.
    Stanojevic C; Bennett CC; Sabanovic S; Collins S; Baugus Henkel K; Henkel Z; Piatt JA
    Front Digit Health; 2023; 5():1208350. PubMed ID: 37519896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multicenter randomized controlled trial of the effects of individual reminiscence therapy on cognition, depression and quality of life: Analysis of a sample of older adults with Alzheimer's disease and vascular dementia.
    Pérez-Sáez E; Justo-Henriques SI; Alves Apóstolo JL
    Clin Neuropsychol; 2022 Oct; 36(7):1975-1996. PubMed ID: 33467972
    [No Abstract]   [Full Text] [Related]  

  • 40. Development, Application, and Results from a Precision-medicine Platform that Personalizes Multi-modal Treatment Plans for Mild Alzheimer's Disease and At-risk Individuals.
    Keine D; Walker JQ; Kennedy BK; Sabbagh MN
    Curr Aging Sci; 2018; 11(3):173-181. PubMed ID: 30338750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.